CSCI.TO

COSCIENS Biopharma Inc.

C$8.32

-2.35%
SectorHealthcareIndustryBiotechnologyCountryCanadaExchangeTSX · CAD
Q-Score49/ 100
Market CapC$8.3M
P/E0.90
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta1.91
AI summary

Price & performance

1M-14.2%
3M+5.9%
YTD-68.1%
1Y-71.1%
52-week range—
Beta1.91
Full chart and returns against a benchmark

Q-Score

49/ 100

Quality against peers; 50 is the peer median.

Growth28
Risk37
Performance36
Valuation87
Profitability65
Leverage41
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

RevenueC$10.3M-25.4%
Net income-C$14.2M
Net margin-138.1%+21.5 pts
Historical fundamentals

Valuation

CSCI.TOIndustryP/E0.9085.07P/S0.7211.67EV/EBITDA—63.25P/B0.396.15PEG—2.86
Dividend yield0.00%
Every valuation metric